Centiva Capital’s Day One Biopharmaceuticals DAWN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,366
Closed -$143K 2238
2024
Q2
$143K Buy
+10,366
New +$152K ﹤0.01% 1779

Other funds holding DAWN

Centiva Capital's DAWN Position: Q3 2024 in Review

Centiva Capital sold out of Day One Biopharmaceuticals (DAWN) in Q3 2024, closing a stake of 10,366 shares — an estimated $143K sold.

Centiva Capital first reported a position in DAWN in Q2 2024 and held it in 1 quarter. The position peaked at $143K in Q2 2024. 166 funds tracked by Wall St. Rank hold DAWN as of Q3 2024.

  • Centiva Capital reported no remaining Day One Biopharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Centiva Capital sold 10,366 Day One Biopharmaceuticals shares in Q3 2024, an estimated $143K.
  • Centiva Capital first reported a position in Day One Biopharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Centiva Capital's Day One Biopharmaceuticals position peaked at $143K in Q2 2024.
  • 166 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.